ITMCTR2200005537招募中4 期
A randomized, double-blind, parallel-controlled, multi-center clinical trial of Chinese medicine variety protection with Niuhuang Qinggan Capsule in the treatment of common cold (wind-heat syndrome)
The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •(1) Meet the diagnostic criteria of Western medicine for common cold; (2) Meet the TCM standard for cold-wind-heat syndrome differentiation; (3) The duration of the cold is =48 hours; (4) Body temperature (axillary temperature) at the time of consultation: 37.3?=body temperature<39? (5) Aged 18 to 65 years old (including 18 and 65 years old), gender is not limited; (6) Subjects gave informed consent, volunteered to be tested and signed the informed consent form.
排除标准
- •(1) Have a confirmed case of influenza, new coronary pneumonia or contact history in an epidemic area within 14 days; (2) Combine any one of the following: herpetic angina, acute pharyngeal conjunctivitis, rhinitis, sinusitis, otitis media, suppurative tonsillitis , bronchiolitis, pulmonary tuberculosis, bronchiectasis or chest X-ray showing pulmonary inflammatory lesions and other diseases; (3) white blood cell count <3.0×109/L or exceeding the upper limit, suspected bacterial infection, or (and) neutrophils The proportion is more than 80%; (4) Complicated with serious primary diseases of the heart, brain, lung, liver, kidney and hematopoietic system; abnormal liver and kidney function ALT, AST = 1.5 times the upper limit of normal; creatinine exceeds the upper limit of normal; (5 ) pregnant, suspected pregnancy, lactating female patients or patients who refused to use contraceptive measures during the study period (including males and females); Chinese medicines or proprietary Chinese medicines with heat-clearing, detoxifying, and throat-relieving effects, or taking nourishing Chinese medicines; taking non-steroidal anti-inflammatory, antipyretic and analgesic drugs within 12 hours; (8) Suspected or actual history of alcohol or drug abuse; (9) Known resistance to experimental drugs or acetaminophen Allergic; (10) Patients who have participated in other clinical trials within three months; (11) Other conditions judged by the investigator or assistant investigator to be inappropriate to participate in the study.
研究者
相似试验
尚未招募
不适用
A randomized, double-blind, parallel-controlled, multicenter trial to evaluate the effectiveness and safety of Xiyanping injection combined with azithromycin and azithromycin in the treatment of mycoplasma pneumoniae pneumonia in childreMycoplasma pneumoniae pneumoniaITMCTR2000003093The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
招募中
4 期
A randomized, double-blind, parallel-controlled, multi-center clinical trial of traditional Chinese medicine variety protection with Wuhu Oral Liquid in the treatment of acute soft tissue injury (Qi stagnation and blood stasis syndrome)acute soft tissue injuryITMCTR2200005606onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
招募中
4 期
A randomized, double-blind, parallel-controlled, multicentre clinical study to evaluate the efficacy and safety of Sechang Zhixie Powder in the treatment of acute watery diarrhea in childreAcute watery diarrheaITMCTR2100004284First Teaching Hospital of Tianjin University of TCM
尚未招募
1 期
A randomized, double-blind, parallel-controlled, multi-center clinical trial of the effectiveness and safety of Fuyanxiao Capsule in the treatment of pelvic inflammatory diseases (damp-heat stasis syndrome)Pelvic inflammatory diseaseITMCTR2100005028Dongfang Hospital, Beijing University of Chinese Medicine
招募中
2 期
Phase II Clinical Trial of Qingke Pingchuan Granules in Treating Acute Bronchitis in ChildreAcute bronchitis in childrenITMCTR2100004581Shanghai Traditional Chinese Medicine Hospital